Growing tissues can crack, break, and dissociate to form structures that can later withstand immense forces.

NYSE-listed Charles River Laboratories International, Inc. is selling some of its assets in two separate transactions.

Jabin Syvrud is one of four current students in the WA-MT Cooperative Program in Veterinary Medicine who plan to be second — or in Jabin’s case, third — generation veterinarians.

UChicago faculty were appointed to distinguished or named professorships on January 1. The Maroon sat down with eight of them ...

Announces Signing of Definitive Agreements to Divest the CDMO and Cell Solutions Businesses and Certain European Discovery Services Assets –– Updates 2026 Financial Guidance –WILMINGTON, ...

Annual R&D Expenses -- $41.1 million in 2025, a 19% decrease driven primarily by a $4.5 million reduction in lab and ...

Announced positive 12-week results from the 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ― ― 20 mg cohort demonstrated rapid and robust fetal hemoglobin ...

Leo, 16, has had a transplant to treat his leukaemia and his mother said he was responding well.

His visit came amid his younger brother, Prince Harry’s, pseudo-royal two-day tour of Jordan with his wife, Meghan Markle.

Investing.com -- Charles River Laboratories International (NYSE:CRL) shares gained 3.5% in premarket trading Wednesday after the company announced plans to divest its CDMO and Cell Solutions ...

Cemsidomide Advancing into Later-stage Development with Potential for Accelerated Approval; First Patient Dosed in the Phase 2 MOMENTUM Trial for Multiple Myeloma in the Fourth Line or Later ...

Members of the American Association for the Advancement of Science have elected Eric D. Isaacs, Ph.D., president of Research ...